Conservative management and female gender are associated with increased cancer-specific death in patients with isolated primary urothelial carcinoma in situ

被引:11
作者
Alanee, S. [1 ,2 ]
Bauman, J. [3 ]
Dynda, D. [4 ]
Frye, T. [3 ]
Konety, B. [5 ]
Schwartz, B. [6 ]
机构
[1] So Illinois Univ, Sch Med, Urol Oncol, Springfield, IL 62794 USA
[2] So Illinois Univ, Sch Med, Dept Surg, Div Urol,Surg, Springfield, IL 62794 USA
[3] So Illinois Univ, Sch Med, Div Urol, Springfield, IL 62794 USA
[4] So Illinois Univ, Sch Med, Clin Res Ctr, Springfield, IL 62794 USA
[5] Univ Minnesota, Sch Med, Dept Urol, Minneapolis, MN 55455 USA
[6] So Illinois Univ, Sch Med, Ctr Laparoscopy Endourol & Stone Dis, Div Urol, Springfield, IL 62794 USA
关键词
bladder cancer; cancer; in situ; management; surgery; SUPERFICIAL BLADDER-CANCER; INTRAVESICAL BCG THERAPY; RADICAL CYSTECTOMY; URINARY-BLADDER; CALMETTE-GUERIN; INVOLVEMENT; MORTALITY; SURVIVAL; DISEASE;
D O I
10.1111/ecc.12217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our goal was to investigate the effect of patient and disease characteristics on the probability of cancer-specific death (CSD) in cases of isolated urothelial carcinoma in situ (CIS). We performed a retrospective analysis of patients diagnosed with isolated CIS between 1990 and 2010 identified from the Surveillance, Epidemiology, and End Results (SEER) database. Competing risk analysis using Cox proportional hazard model was used to examine the probability of CSD controlling for possible covariates. Overall (n = 1432), patients were mainly male (75%), mean age at diagnosis was 71years, median survival 47months, and 65% of the patients had CIS in their upper urinary tract. Caucasians were the predominant race (90%). CIS was the cause of death in 87/1432(6%) of the total cohort; 69/1239 (6%) of patients who underwent surgery, and 18/193 (9%) of the patients who were managed conservatively (CM). On multivariate analysis, CM [hazard ration (HR) = 2.019, CI: 1.189-3.429, P = 0.009] and female gender (HR = 1.690, CI: 1.041-2.741, P = 0.033) were associated with CSD, while age, site, race and year of diagnosis were non-significant predictors. Female gender and conservative management were positively associated with CSD. Multi-institutional collaboration is needed to validate markers for poor prognosis in cases of isolated CIS.
引用
收藏
页码:444 / 449
页数:6
相关论文
共 23 条
[11]   Gender differences in stage distribution of bladder cancer [J].
Mungan, NA ;
Kiemeney, LALM ;
van Dijck, JAAM ;
van der Poel, HG ;
Witjes, JA .
UROLOGY, 2000, 55 (03) :368-371
[12]   Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients [J].
Noon, A. P. ;
Albertsen, P. C. ;
Thomas, F. ;
Rosario, D. J. ;
Catto, J. W. F. .
BRITISH JOURNAL OF CANCER, 2013, 108 (07) :1534-1540
[13]   Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the Bladder [J].
Otto, Wolfgang ;
May, Matthias ;
Fritsche, Hans-Martin ;
Dragun, Duska ;
Aziz, Atiqullah ;
Gierth, Michael ;
Trojan, Lutz ;
Herrmann, Edwin ;
Moritz, Rudolf ;
Ellinger, Joerg ;
Tilki, Derya ;
Buchner, Alexander ;
Hoefner, Thomas ;
Brookman-May, Sabine ;
Nuhn, Philipp ;
Gilfrich, Christian ;
Roigas, Jan ;
Zacharias, Mario ;
Denzinger, Stefan ;
Hohenfellner, Markus ;
Haferkamp, Axel ;
Mueller, Stefan C. ;
Kocot, Arkadius ;
Riedmiller, Hubertus ;
Wieland, Wolf F. ;
Stief, Christian G. ;
Bastian, Patrick J. ;
Burger, Maximilian .
GENDER MEDICINE, 2012, 9 (06) :481-489
[14]   Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer [J].
Saint, F ;
Patard, JJ ;
Maille, P ;
Soyeux, P ;
Hoznek, A ;
Salomon, L ;
Abbou, CC ;
Chopin, DK .
JOURNAL OF UROLOGY, 2002, 167 (01) :364-367
[15]   Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy [J].
Shariat, Shahrokh F. ;
Palapattu, Ganesh S. ;
Karakiewicz, Pierre I. ;
Rogers, Craig G. ;
Vazina, Amnon ;
Bastian, Patrick J. ;
Schoenberg, Mark P. ;
Lerner, Seth P. ;
Sagalowsky, Arthur I. ;
Lotan, Yair .
EUROPEAN UROLOGY, 2007, 51 (01) :152-160
[16]   Extravesical involvement in patients with bladder carcinoma in situ: Biological and therapy implications [J].
Solsona, E ;
Iborra, I ;
Ricos, JV ;
Monros, JL ;
Dumont, R ;
Almenar, S .
JOURNAL OF UROLOGY, 1996, 155 (03) :895-899
[17]   The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer [J].
Solsona, E ;
Iborra, I ;
Dumont, R ;
Rubio-Briones, J ;
Casanova, J ;
Almenar, S .
JOURNAL OF UROLOGY, 2000, 164 (03) :685-689
[18]   High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder [J].
Sylvester, RJ ;
van der Meijden, A ;
Witjes, JA ;
Jakse, G ;
Nonomura, N ;
Cheng, C ;
Torres, A ;
Watson, R ;
Kurth, KH .
UROLOGY, 2005, 66 (6A) :90-107
[19]   Increased Infiltration of Tumor Associated Macrophages is Associated With Poor Prognosis of Bladder Carcinoma In Situ After Intravesical Bacillus Calmette-Guerin Instillation [J].
Takayama, Hitoshi ;
Nishimura, Kazuo ;
Tsujimura, Akira ;
Nakai, Yasutomo ;
Nakayama, Masashi ;
Aozasa, Katsuyuki ;
Okuyama, Akihiko ;
Nonomura, Norio .
JOURNAL OF UROLOGY, 2009, 181 (04) :1894-1900
[20]   Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients [J].
Tilki, Derya ;
Reich, Oliver ;
Svatek, Robert S. ;
Karakiewicz, Pierre I. ;
Kassouf, Wassim ;
Novara, Giacomo ;
Ficarra, Vincenzo ;
Chade, Daher C. ;
Fritsche, Hans-Martin ;
Gerwens, Niklas ;
Izawa, Jonathan I. ;
Lerner, Seth P. ;
Schoenberg, Mark ;
Stief, Christian G. ;
Skinner, Eila ;
Lotan, Yair ;
Sagalowsky, Arthur I. ;
Shariat, Shahrokh F. .
JOURNAL OF UROLOGY, 2010, 183 (05) :1757-1763